Follow the 인트론바이오 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 인트론바이오 has published 37 insider filings. Market capitalisation: €73.7bn. The latest transaction was filed on 3 July 2026 (Other). Among the most active insiders: 윤성준. All data is free.
37
Insider Decl.
0
Thresholds
·
11 ops.
Buy Volume
·
5 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,003 of 26,213 companies
30.5
score / 100
Value
16
Quality
45
FCF yld-9.6%
Earn yld-11%
EV/EBITDA·
ROE-12%
Gross mgn54%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
인트론바이오 is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative biopharmaceutical solutions.